We have changed our domainWe have changed servers and operate Career|edu under a different domain. Our services will remain unchanged and we will continue to post the best career openings for the academic world at our new domain.
Go back to the Job List
Cellular and Molecular BiologyPosted by: Postdoc positions by NIH
Posted date: 2020-Apr-14
*Applications will be reviewed on a rolling-basis.
A research opportunity is currently available with the Division of Cellular and Gene Therapies, in the Office of Tissues and Advanced Therapies (OTAT), at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) located in Silver Spring, Maryland.
The main aim of this project is to examine the critical quality attributes (CQA) of CAR-T cell products manufactured by conventional and automated advanced manufacturing systems including closed/contained and bio-reactor platforms. A large number of CAR-T cells are needed to characterize CQAs in vitro and study safety and bio-distribution of CAR-T cells in vivo in mouse models of human cancers. The project aims at studying important issues of product manufacturing, which should be flexible, scalable and reproducible ensuring GMP-compliant products and finally should be cost-effective.
The research will focus on comparative assessment of CQA of human CAR-T cell product targeted to IL-13Ra2 (phenotypic and functional assessment) produced by different platform technologies. The study will also focus on optimization of critical process parameters for the isolation, activation and transduction of T cells by lentiviral vectors for production of CAR-T cells. The manufacturing technologies may include closed system, conventional approach and bioreactor expansion of CAR-T cells. Under the guidance of a mentor, the participant will learn how to produce, purify and evaluate lentiviral gene therapy vectors and test them in vitro and in vivo animal models of human cancers.
Anticipated Appointment Start Date: as early as May 8, 2020
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.Qualifications:
The qualified candidate should have received a doctoral degree in a Life Health and Medical Sciences field, or be currently pursuing the degree and will reach completion by the appointment start date. Degree must have been received within five years of the appointment start date.
A complete application consists of:
If you have questions, send an email to ORISE.FDA.CBERorau.org. Please include the reference code for this opportunity (FDA-CBER-2020-0030) in your email.
Application Deadline: September 14, 2020 3:00PM EST
This post will be available until July 14, 2020 or until filled.
The NIH is dedicated to building a diverse community in its training and employment programs.